Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 456
interventional 321
Observational 128
Registry 7

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 101
Biological 80
Biological|placebo 45
Drug|placebo 43
Other 12
Behavioral 6
Procedure 6
Biological|Drug 4
Combination Product 4
Dietary Supplement|placebo 4
Biological|Other 3
Device 2
Drug|Other 2
Behavioral|Other 1
Biological|Other|placebo 1
Biological|Procedure 1
Device|Drug 1
Diagnostic Test 1
Diagnostic Test|Other 1
Drug|Procedure 1
Drug|Procedure|Radiation 1
Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 95
NA 35
China 25
United Kingdom 14
Russian Federation 12
Canada 11
France 6
Japan 6
United States|Canada 6
Germany 5
United States|Puerto Rico 5
Australia 4
Greece 4
Brazil 3
Denmark 3
Netherlands 3
Spain 3
Belgium 2
Chile 2
Congo, The Democratic Republic of the 2
Cuba 2
Guinea 2
Korea, Republic of 2
Mali 2
Norway 2
Sierra Leone 2
Taiwan 2
Uganda 2
Australia|Hong Kong|Israel|Lebanon|Malaysia|Poland|Taiwan|Turkey 1
Austria 1
Austria|Belgium|Netherlands 1
Austria|Germany|Switzerland 1
Belarus|Russian Federation|Ukraine 1
Belgium|Brazil|France|Austria|United States|Australia|Germany|Ireland|Mexico|Poland|Spain|Sweden|United Kingdom 1
Belgium|Finland|France|Germany|Netherlands|Spain|United Kingdom 1
Belgium|France|Germany|Italy|Poland|Spain|United Kingdom 1
Belgium|France|Germany|United Kingdom 1
Belgium|Germany|Netherlands 1
Bulgaria 1
Bulgaria|China|Hong Kong|Korea, Republic of|New Zealand|Poland|Taiwan|United Kingdom 1
Cameroon|Mali|Nigeria|Senegal 1
Canada|Moldova, Republic of|Ukraine 1
Czechia 1
Czechia|United States|Belgium|Brazil|Canada|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Malaysia|Poland|Russian Federation|Spain|Thailand|Turkey|United Kingdom 1
Egypt 1
Estonia|Germany|Mexico|Thailand|United Kingdom 1
Finland 1
France|United Kingdom 1
Germany|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Colombia|Czechia|Estonia|Finland|France|Hungary|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Mexico|New Zealand|Panama|Poland|Russian Federation|South Africa|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
Gibraltar 1
Guinea|Russian Federation 1
Guinea|Sierra Leone 1
Iran, Islamic Republic of 1
Israel|New Zealand|Pakistan 1
Italy 1
Kazakhstan|Russian Federation 1
Liberia 1
Mali|Senegal 1
Nigeria|Niger 1
Poland 1
Romania 1
Russian Federation|Sweden 1
Senegal 1
Sierra Leone|Guinea|Liberia|Mali 1
Spain|Switzerland|United Kingdom 1
Switzerland 1
Thailand 1
Uganda|Congo, The Democratic Republic of the 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|France|Germany|Israel|Italy|Japan|Korea, Republic of|Malaysia|Netherlands|Russian Federation|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Brazil|France|Italy|Korea, Republic of|Spain|Taiwan 1
United States|Australia|Belgium|Canada|Czech Republic|France|Germany|Greece|Ireland|Italy|Netherlands|Poland|Puerto Rico|Russian Federation|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Netherlands|United Kingdom 1
United States|Australia|Canada|Korea, Republic of|New Zealand 1
United States|Australia|Chile|New Zealand|Panama 1
United States|Australia|Puerto Rico 1
United States|Australia|South Africa 1
United States|Belgium|Canada|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Malaysia|Poland|Russian Federation|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Belgium|Canada|Hong Kong|India|Korea, Republic of|New Zealand|Romania|Russian Federation|Taiwan 1
United States|Brazil|Colombia|Costa Rica|Ecuador|Mexico|Panama|Peru|Puerto Rico 1
United States|Canada|Finland|Germany|Philippines|Thailand|United Kingdom 1
United States|Canada|Finland|Germany|Thailand 1
United States|Canada|France|Italy|Poland|Puerto Rico|Spain 1
United States|Chile|South Africa 1
United States|Congo, The Democratic Republic of the 1
United States|New Zealand 1
United States|United Kingdom 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 179
2 28
3 8
4 11
5 7
6 7
7 3
8 4
9 7
10 4
11 8
12 4
13 6
14 2
15 3
16 1
17 4
18 3
19 2
20 2
22 2
23 1
26 1
27 1
28 2
30 1
32 1
33 2
34 2
37 1
39 1
40 1
41 1
42 1
54 1
55 1
73 1
76 1
102 1
104 1
112 1
129 1
145 1
277 1

Phase

Phase Study_Count
Phase 2 85
Phase 1 79
Phase 3 62
N/A 37
Phase 4 27
Phase 1/Phase 2 17
Phase 2/Phase 3 11
Early Phase 1 3

Number of Arms

Number_of_Arms Count_of_Studies
1 74
2 120
3 30
4 34
5 16
6 13
7 4
8 4
9 1
10 2
12 1
NA 22

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 20.0 10.000 1.00000 10.0000 2.0 10.0000 28.000 15.0000
1st Qu. 29.5 38.250 22.00000 36.0000 50.0 110.0000 136.000 54.0000
Median 39.0 129.500 44.00000 86.0000 103.0 245.0000 295.000 131.0000
Mean 455.0 2184.306 55.41558 119.7059 326.4 446.4545 9247.967 503.6667
3rd Qu. 672.5 281.250 72.00000 160.0000 255.0 463.0000 1023.000 349.5000
Max. 1306.0 70190.000 271.00000 450.0000 4789.0 1500.0000 500000.000 4000.0000

Trial Group Type

group_type Group_Count
Experimental 549
Placebo Comparator 109
Active Comparator 94
No Intervention 23
NA 22
Other 21
Sham Comparator 3

Intervention Model

intervention_model Study_Count
Parallel Assignment 202
Single Group Assignment 87
Sequential Assignment 13
NA 11
Crossover Assignment 5
Factorial Assignment 3

Primary Purpose

primary_purpose Study_Count
Treatment 161
Prevention 129
NA 9
Basic Science 7
Health Services Research 6
Diagnostic 4
Other 4
Supportive Care 1

Observational Studies

Studies by Country

Country Study_Count
United States 35
France 13
NA 12
China 6
Switzerland 5
Canada 4
Israel 4
United Kingdom 4
Brazil 3
Denmark 3
Mexico 3
Austria 2
Germany 2
India 2
Japan 2
Spain 2
Taiwan 2
Argentina|Chile|Colombia|Ecuador|Mexico|Peru|Uruguay 1
Australia 1
Brazil|Colombia|Guatemala|Nicaragua|Peru|Puerto Rico 1
Cameroon 1
Colombia|Honduras|Mexico|Puerto Rico 1
Congo, The Democratic Republic of the 1
Czech Republic 1
Egypt 1
Hong Kong 1
India|United States|Argentina|Brazil|China|France|Greece|Italy|Peru|Philippines|Poland|Romania|Russian Federation|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
Italy 1
Korea, Republic of 1
Liberia 1
Nicaragua 1
Norway 1
Peru 1
Sierra Leone 1
Slovenia 1
Turkey 1
United States|Argentina|Australia|Belgium|Chile|Denmark|Germany|Greece|Peru|Spain|Thailand|United Kingdom 1
United States|Canada 1
United States|Lebanon 1
United States|Liberia 1
Zambia 1

Sites per Study

Site_count Study_Count
1 87
2 13
3 3
4 5
5 1
6 4
7 2
10 2
11 1
15 1
23 1
24 1
26 1
28 1
44 1
45 2
63 1
86 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 110.750
Median 346.500
Mean 2468.246
3rd Qu 1000.000
Max 114035.000

Observation Model

observational_model Study_Count
Cohort 75
Case-Only 17
NA 12
Case Control 8
Other 7
Case-Control 6
Ecologic or Community 3

Time Perspective

time_perspective Study_Count
Prospective 93
Retrospective 15
Cross-Sectional 8
Other 6
NA 6

Registries

Studies by Country

Country Study_Count
Italy 2
Chile 1
Colombia 1
Egypt 1
Germany 1
Sweden 1

Sites per Study

Site_count Study_Count
1 5
2 1
18 1

Enrollment Metrics

Measure Registries
Min 20.0000
1st Qu 125.0000
Median 325.0000
Mean 442.1429
3rd Qu 650.0000
Max 1200.0000

Registry Model

observational_model Study_Count
Cohort 5
Case-Control 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 4
Other 2
Cross-Sectional 1

Follow-up

target_duration Study_Count
3 Months 3
1 Day 1
1 Year 1
24 Weeks 1
3 Weeks 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03361956 An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection https://ClinicalTrials.gov/show/NCT03361956 Active, not recruiting Janssen Sciences Ireland UC 2019-09-05
NCT03389997 Assessement of Viral Shedding Duration After a Respiratory Tract Infection in Oncology and Hematology Patients https://ClinicalTrials.gov/show/NCT03389997 Recruiting Poitiers University Hospital 2021-01-09
NCT03369327 Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus https://ClinicalTrials.gov/show/NCT03369327 Completed Tehran University of Medical Sciences 2018-09-01
NCT04310228 Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 https://ClinicalTrials.gov/show/NCT04310228 Recruiting Peking University First Hospital 2020-05-31
NCT03800173 A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430 https://ClinicalTrials.gov/show/NCT03800173 Active, not recruiting BioCryst Pharmaceuticals 2019-04-30
NCT03357757 Avelumab With Valproic Acid in Virus-associated Cancer https://ClinicalTrials.gov/show/NCT03357757 Recruiting AHS Cancer Control Alberta 2022-03-30
NCT03343626 Safety, Immunogenicity and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Adult Participants https://ClinicalTrials.gov/show/NCT03343626 Active, not recruiting Takeda 2018-12-28
NCT03336086 Effect of Weight Reduction on Immunity https://ClinicalTrials.gov/show/NCT03336086 Completed Shiraz University of Medical Sciences 2012-11-30
NCT03334695 An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old Adults https://ClinicalTrials.gov/show/NCT03334695 Completed Janssen Vaccines & Prevention B.V. 2018-07-10
NCT03332459 A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection https://ClinicalTrials.gov/show/NCT03332459 Completed Janssen Research & Development, LLC 2020-04-13
NCT03321968 Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT03321968 Completed Medicago 2017-12-01
NCT03312023 Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection https://ClinicalTrials.gov/show/NCT03312023 Recruiting University of Maryland, Baltimore 2020-08-31
NCT03301051 Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Adults https://ClinicalTrials.gov/show/NCT03301051 Completed Medicago 2018-05-02
NCT03294473 Centralized Reminder Recall - Flu RCT2 https://ClinicalTrials.gov/show/NCT03294473 Completed University of California, Los Angeles 2018-04-19
NCT03294135 The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals’ Encepur Adults Vaccine https://ClinicalTrials.gov/show/NCT03294135 Active, not recruiting GlaxoSmithKline 2022-07-14
NCT03258502 Safety, Pharmacokinetics and Antiviral Activity of RV521 Against RSV https://ClinicalTrials.gov/show/NCT03258502 Completed ReViral Ltd 2017-10-31
NCT03250910 Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients https://ClinicalTrials.gov/show/NCT03250910 Completed National Taiwan University Hospital 2017-07-15
NCT03206346 Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o. https://ClinicalTrials.gov/show/NCT03206346 Completed Valenta Pharm JSC 2012-11-30
NCT03191097 Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o. https://ClinicalTrials.gov/show/NCT03191097 Completed Valenta Pharm JSC 2014-12-31
NCT03189537 Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections https://ClinicalTrials.gov/show/NCT03189537 Completed Valenta Pharm JSC 2011-04-19
NCT03180216 T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT03180216 Recruiting Children’s National Research Institute 2020-07-31
NCT03166943 the Possible Effect of the Antiviral Inhibitors for Treatment of Hepatitis C Virus Infection in Cardiac Function https://ClinicalTrials.gov/show/NCT03166943 Recruiting Assiut University 2020-12-31
NCT03163628 biomArkers to differeNtiate bacTerial From vIral iNfEctions https://ClinicalTrials.gov/show/NCT03163628 Completed Hospices Civils de Lyon 2019-06-12
NCT03161366 Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine https://ClinicalTrials.gov/show/NCT03161366 Completed Epicentre 2018-07-14
NCT03154515 Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults https://ClinicalTrials.gov/show/NCT03154515 Completed Valenta Pharm JSC 2014-04-30
NCT03119025 Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection https://ClinicalTrials.gov/show/NCT03119025 Completed Russian Academy of Medical Sciences 2018-02-28
NCT03110770 VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents https://ClinicalTrials.gov/show/NCT03110770 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2019-10-04
NCT03079609 The Search for Viral and Bacterial Etiology of Varicocele https://ClinicalTrials.gov/show/NCT03079609 Active, not recruiting Medical University of Warsaw 2019-12-31
NCT03072030 International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi https://ClinicalTrials.gov/show/NCT03072030 Active, not recruiting Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 2019-12-31
NCT03051386 Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT03051386 Active, not recruiting U.S. Army Medical Research and Development Command 2022-04-01
NCT03039621 Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children https://ClinicalTrials.gov/show/NCT03039621 Completed Materia Medica Holding 2019-01-09
NCT02996682 Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT02996682 Completed Gilead Sciences 2018-02-13
NCT02993250 A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive https://ClinicalTrials.gov/show/NCT02993250 Completed Janssen Pharmaceutical K.K. 2018-05-07
NCT02991872 A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children https://ClinicalTrials.gov/show/NCT02991872 Completed GlaxoSmithKline 2017-03-12
NCT02968173 A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus https://ClinicalTrials.gov/show/NCT02968173 Completed AbbVie 2017-07-13
NCT02876328 Partnership for Research on Ebola VACcinations https://ClinicalTrials.gov/show/NCT02876328 Active, not recruiting National Institute of Allergy and Infectious Diseases (NIAID) 2020-05-01
NCT02847156 Impact of Respiratory Viral Infections in Infants With Cystic Fibrosis. https://ClinicalTrials.gov/show/NCT02847156 Completed Hospices Civils de Lyon 2016-01-31
NCT02831751 Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults https://ClinicalTrials.gov/show/NCT02831751 Completed Medicago 2016-07-31
NCT02825212 Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia https://ClinicalTrials.gov/show/NCT02825212 Completed Icahn School of Medicine at Mount Sinai 2019-07-19
NCT02822794 Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen https://ClinicalTrials.gov/show/NCT02822794 Completed Gilead Sciences 2017-06-02
NCT02781571 Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant https://ClinicalTrials.gov/show/NCT02781571 Completed Gilead Sciences 2017-07-28
NCT02776761 A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine https://ClinicalTrials.gov/show/NCT02776761 Recruiting U.S. Army Medical Research and Development Command 2020-11-30
NCT02768805 Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT02768805 Completed Medicago 2016-05-17
NCT02765802 A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection https://ClinicalTrials.gov/show/NCT02765802 Completed Eiger BioPharmaceuticals 2018-06-20
NCT02738138 A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) https://ClinicalTrials.gov/show/NCT02738138 Completed AbbVie 2017-03-15
NCT02733068 A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine. https://ClinicalTrials.gov/show/NCT02733068 Active, not recruiting Shanghai Zerun Biotechnology Co.,Ltd 2018-12-31
NCT02723084 A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02723084 Completed AbbVie 2017-01-19
NCT02722837 Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02722837 Completed Gilead Sciences 2017-06-26
NCT02718469 Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT02718469 Completed Auro Vaccines LLC 2016-09-15
NCT02716428 A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02716428 Completed Trek Therapeutics, PBC 2017-09-30
NCT02707952 A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02707952 Completed AbbVie 2016-11-14
NCT02662855 Efficacy of Favipiravir Against Severe Ebola Virus Disease https://ClinicalTrials.gov/show/NCT02662855 Completed Beijing Institute of Pharmacology and Toxicology 2015-04-30
NCT02654171 Viral Inhibition in Children for Treatment of RSV https://ClinicalTrials.gov/show/NCT02654171 Completed Ark Biosciences Inc. 2019-03-31
NCT02644018 Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o. https://ClinicalTrials.gov/show/NCT02644018 Completed Valenta Pharm JSC 2016-05-31
NCT02640157 A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection https://ClinicalTrials.gov/show/NCT02640157 Completed AbbVie 2016-10-31
NCT02630082 Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru https://ClinicalTrials.gov/show/NCT02630082 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2013-03-31
NCT02609659 Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02609659 Completed AbbVie 2016-10-07
NCT02593162 A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02593162 Completed Trek Therapeutics, PBC 2016-12-31
NCT03309020 PREVAIL VII: Persistence of Ebola Virus in Aqueous Humor and Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease https://ClinicalTrials.gov/show/NCT03309020 Completed National Institutes of Health Clinical Center (CC) 2019-08-01
NCT02575456 A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine https://ClinicalTrials.gov/show/NCT02575456 Completed Jiangsu Province Centers for Disease Control and Prevention 2016-06-30
NCT02570126 A Safety and Immune Study of 2 Types of GlaxoSmithKline’s Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age. https://ClinicalTrials.gov/show/NCT02570126 Completed GlaxoSmithKline 2016-10-25
NCT02558803 HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 https://ClinicalTrials.gov/show/NCT02558803 Completed Regenstrief Institute, Inc. 2016-05-31
NCT02932150 Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection https://ClinicalTrials.gov/show/NCT02932150 Recruiting Gilead Sciences 2023-02-28
NCT02509494 Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo https://ClinicalTrials.gov/show/NCT02509494 Completed Janssen Vaccines & Prevention B.V. 2019-06-28
NCT02551887 HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts https://ClinicalTrials.gov/show/NCT02551887 Completed Regenstrief Institute, Inc. 2015-04-30
NCT02548078 A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children https://ClinicalTrials.gov/show/NCT02548078 Completed GlaxoSmithKline 2017-05-15
NCT02546752 Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine https://ClinicalTrials.gov/show/NCT02546752 Completed Regenstrief Institute, Inc. 2016-05-31
NCT02545517 A Clinical Study to Evaluate Immune Responses to Rabies Vaccine in Adults Who Received Different Primary Rabies Vaccination Regimens https://ClinicalTrials.gov/show/NCT02545517 Active, not recruiting GlaxoSmithKline 2022-12-05
NCT02534350 Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection https://ClinicalTrials.gov/show/NCT02534350 Completed Gilead Sciences 2017-02-20
NCT02533791 A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization https://ClinicalTrials.gov/show/NCT02533791 Completed Jiangsu Province Centers for Disease Control and Prevention 2015-09-30
NCT02532452 Third Party Anti-Viral Cytotoxic T-Cells https://ClinicalTrials.gov/show/NCT02532452 Recruiting Children’s Hospital Medical Center, Cincinnati 2021-08-31
NCT02510417 Allogeneic Virus-specific T Cell Lines (VSTs) https://ClinicalTrials.gov/show/NCT02510417 Recruiting Children’s National Research Institute 2020-08-31
NCT02510404 Multivirus-specific Cytotoxic T Lymphocytes (mCTL) https://ClinicalTrials.gov/show/NCT02510404 Completed Children’s National Research Institute 2019-05-08
NCT02495246 A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV https://ClinicalTrials.gov/show/NCT02495246 Completed University of Oxford 2017-08-22
NCT02491463 A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals’ RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults https://ClinicalTrials.gov/show/NCT02491463 Completed GlaxoSmithKline 2016-04-08
NCT02485912 Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination https://ClinicalTrials.gov/show/NCT02485912 Completed University of Oxford 2016-01-31
NCT02485301 A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults https://ClinicalTrials.gov/show/NCT02485301 Completed GlaxoSmithKline 2016-12-23
NCT02479698 Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus https://ClinicalTrials.gov/show/NCT02479698 Recruiting M.D. Anderson Cancer Center 2020-07-31
NCT02472548 A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine https://ClinicalTrials.gov/show/NCT02472548 Completed Dalhousie University 2017-03-14
NCT02469298 Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza https://ClinicalTrials.gov/show/NCT02469298 Completed GlaxoSmithKline 2016-04-25
NCT02447705 Replacement of Lamivudine by Telbivudine to Improve Renal Function https://ClinicalTrials.gov/show/NCT02447705 Completed Chang Gung Memorial Hospital 2016-12-31
NCT02416453 A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults https://ClinicalTrials.gov/show/NCT02416453 Completed Janssen Vaccines & Prevention B.V. 2018-01-19
NCT02401373 A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China. https://ClinicalTrials.gov/show/NCT02401373 Completed First Affiliated Hospital of Zhejiang University 2015-07-31
NCT02387606 Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection. https://ClinicalTrials.gov/show/NCT02387606 Completed Janssen Sciences Ireland UC 2015-09-21
NCT02368119 Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO) https://ClinicalTrials.gov/show/NCT02368119 Completed University of Maryland, Baltimore 2016-09-27
NCT02351180 Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients https://ClinicalTrials.gov/show/NCT02351180 Active, not recruiting Washington University School of Medicine 2021-04-30
NCT02350569 Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting https://ClinicalTrials.gov/show/NCT02350569 Completed Gilead Sciences 2016-03-28
NCT02342171 Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea https://ClinicalTrials.gov/show/NCT02342171 Completed Institute of Tropical Medicine, Belgium 2015-07-31
NCT02337868 Phase 1 Trial of Inactivated West Nile Virus Vaccine https://ClinicalTrials.gov/show/NCT02337868 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2016-12-16
NCT02336139 A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use https://ClinicalTrials.gov/show/NCT02336139 Completed Kirby Institute 2017-04-17
NCT02329054 Efficacy of Favipiravir Against Ebola (JIKI) https://ClinicalTrials.gov/show/NCT02329054 Completed Institut National de la Santé Et de la Recherche Médicale, France 2015-05-31
NCT02326194 A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults. https://ClinicalTrials.gov/show/NCT02326194 Completed Jiangsu Province Centers for Disease Control and Prevention 2015-02-28
NCT02309918 HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02309918 Completed HepNet Study House, German Liverfoundation 2016-08-31
NCT02295501 A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease https://ClinicalTrials.gov/show/NCT02295501 Enrolling by invitation Cerus Corporation 2020-12-31
NCT02292719 A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02292719 Completed AbbVie 2017-07-14
NCT02290340 A Phase 1b/2a Randomized, Double-Blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants https://ClinicalTrials.gov/show/NCT02290340 Completed MedImmune LLC 2016-09-28
NCT02267109 Phase 1 Trial of Ebola Vaccine in Mali https://ClinicalTrials.gov/show/NCT02267109 Completed University of Maryland, Baltimore 2016-04-20
NCT02254707 Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection https://ClinicalTrials.gov/show/NCT02254707 Completed Boehringer Ingelheim 2006-04-30
NCT02253550 Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02253550 Completed Peter J. Ruane, M.D., Inc. 2016-01-31
NCT02250807 Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02250807 Completed Janssen R&D Ireland 2015-12-31
NCT02250274 Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents https://ClinicalTrials.gov/show/NCT02250274 Completed Marshfield Clinic Research Foundation 2014-12-31
NCT02236052 Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population https://ClinicalTrials.gov/show/NCT02236052 Completed Medicago 2015-06-17
NCT02233816 Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults https://ClinicalTrials.gov/show/NCT02233816 Completed Medicago 2015-06-22
NCT02226952 Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02226952 Completed Boehringer Ingelheim 2002-04-30
NCT02219477 A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis https://ClinicalTrials.gov/show/NCT02219477 Completed AbbVie 2016-06-13
NCT02185794 Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02185794 Completed Gilead Sciences 2014-12-31
NCT02183753 Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers https://ClinicalTrials.gov/show/NCT02183753 Completed University of North Carolina, Chapel Hill 2015-03-31
NCT02115815 A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults https://ClinicalTrials.gov/show/NCT02115815 Completed MedImmune LLC 2015-06-30
NCT02114385 A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020) https://ClinicalTrials.gov/show/NCT02114385 Completed Merck Sharp & Dohme Corp. 2015-04-22
NCT02114177 Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis https://ClinicalTrials.gov/show/NCT02114177 Completed Janssen Infectious Diseases BVBA 2015-01-31
NCT02114151 Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis https://ClinicalTrials.gov/show/NCT02114151 Completed Janssen Infectious Diseases BVBA 2015-01-31
NCT02108522 Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant https://ClinicalTrials.gov/show/NCT02108522 Completed AlloVir 2018-01-31
NCT02103023 Intradermal Influenza Vaccine in the Young https://ClinicalTrials.gov/show/NCT02103023 Completed The University of Hong Kong 2014-11-30
NCT02072174 Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children https://ClinicalTrials.gov/show/NCT02072174 Completed Materia Medica Holding 2018-04-16
NCT02061358 Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects https://ClinicalTrials.gov/show/NCT02061358 Completed Unither Virology 2015-07-31
NCT01316237 A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT01316237 Completed Gilead Sciences 2011-10-31
NCT01308424 Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection https://ClinicalTrials.gov/show/NCT01308424 Completed Beech Tree Labs, Inc. 2012-10-31
NCT01273246 Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children https://ClinicalTrials.gov/show/NCT01273246 Completed Sinovac Biotech Co., Ltd 2011-06-30
NCT01273233 Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT01273233 Completed Sinovac Biotech Co., Ltd 2011-02-28
NCT02048332 Anti-viral Treatment Following Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT02048332 Recruiting Children’s Hospital Medical Center, Cincinnati 2023-03-31
NCT03959488 A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children https://ClinicalTrials.gov/show/NCT03959488 Recruiting MedImmune LLC 2022-12-02
NCT02013934 Probiotics in Prevention of Common Cold https://ClinicalTrials.gov/show/NCT02013934 Completed Probi AB 2016-05-31
NCT02012998 Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA https://ClinicalTrials.gov/show/NCT02012998 Completed Sanofi 2015-02-28
NCT02007356 A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® https://ClinicalTrials.gov/show/NCT02007356 Recruiting University Hospital, Basel, Switzerland 2020-12-31
NCT02003703 Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . https://ClinicalTrials.gov/show/NCT02003703 Completed Universidad de Valparaiso 2018-06-30
NCT01991587 Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults https://ClinicalTrials.gov/show/NCT01991587 Completed Medicago 2014-06-30
NCT01991561 Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine. https://ClinicalTrials.gov/show/NCT01991561 Completed Medicago 2014-07-31
NCT01957878 Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL https://ClinicalTrials.gov/show/NCT01957878 Completed Genticel 2016-10-31
NCT01939197 A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection https://ClinicalTrials.gov/show/NCT01939197 Completed AbbVie 2016-07-21
NCT01924117 Genotypification and Predisposing Factors in Human Papilloma Virus Infection https://ClinicalTrials.gov/show/NCT01924117 Completed Materno-Perinatal Hospital of the State of Mexico 2011-05-31
NCT01892358 Preventing Bacterial and Viral Infections Among Injection Drug Users https://ClinicalTrials.gov/show/NCT01892358 Completed Butler Hospital 2019-08-31
NCT01883180 ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis https://ClinicalTrials.gov/show/NCT01883180 Completed Nanfang Hospital of Southern Medical University 2017-09-30
NCT01854697 A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before https://ClinicalTrials.gov/show/NCT01854697 Completed AbbVie 2014-11-30
NCT01842997 Safety of H1N1 Influenza Vaccination in Pregnant Women https://ClinicalTrials.gov/show/NCT01842997 Completed Jiangsu Province Centers for Disease Control and Prevention 2010-12-31
NCT01839188 Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) https://ClinicalTrials.gov/show/NCT01839188 Completed MCM Vaccines B.V. 2014-03-19
NCT01839175 Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination https://ClinicalTrials.gov/show/NCT01839175 Completed Sanofi 2014-07-31
NCT01819792 Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia https://ClinicalTrials.gov/show/NCT01819792 Completed Centre Hospitalier Universitaire, Amiens 2016-07-31
NCT01806103 Antimicrobial Stewardship for Primary Care Pediatricians https://ClinicalTrials.gov/show/NCT01806103 Completed Children’s Hospital of Philadelphia 2011-06-30
NCT01800071 A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01800071 Completed Cancer Research UK 2017-03-10
NCT01724203 Effect of 12-week Probiotic Supplementation on Bacterial and Viral Infections in Infants Aged 6 to 12 Months. https://ClinicalTrials.gov/show/NCT01724203 Completed Fonterra Research Centre 2013-04-30
NCT01708889 Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction https://ClinicalTrials.gov/show/NCT01708889 Completed Bristol-Myers Squibb 2013-02-28
NCT01689285 Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir https://ClinicalTrials.gov/show/NCT01689285 Completed Radboud University 2015-07-31
NCT01685203 A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT01685203 Completed AbbVie 2014-06-30
NCT01682109 Palatability Testing of a New Paediatric Formulation of Valacyclovir https://ClinicalTrials.gov/show/NCT01682109 Completed Radboud University 2016-03-31
NCT01672983 A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT01672983 Completed AbbVie 2014-05-31
NCT01666782 Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT01666782 Completed Rochester General Hospital 2015-06-30
NCT01624948 Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients https://ClinicalTrials.gov/show/NCT01624948 Completed University of California, San Francisco 2015-02-28
NCT01604746 Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801 https://ClinicalTrials.gov/show/NCT01604746 Completed Ology Bioservices 2013-04-30
NCT01590654 A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection https://ClinicalTrials.gov/show/NCT01590654 Completed Gilead Sciences 2013-11-30
NCT01587131 DNA-based Influenza Vaccine in the Elderly https://ClinicalTrials.gov/show/NCT01587131 Completed University of Manitoba 2014-08-31
NCT01553279 Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) https://ClinicalTrials.gov/show/NCT01553279 Completed MCM Vaccines B.V. 2013-09-27
NCT01546506 Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected Cells https://ClinicalTrials.gov/show/NCT01546506 Completed Hospices Civils de Lyon 2014-03-31
NCT01502072 Respiratory Syncytial Virus - RSV Protocol https://ClinicalTrials.gov/show/NCT01502072 Completed M.D. Anderson Cancer Center 2020-02-01
NCT01494103 Administration of Donor T Cells With the Caspase-9 Suicide Gene https://ClinicalTrials.gov/show/NCT01494103 Active, not recruiting Baylor College of Medicine 2029-05-31
NCT01480258 Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) https://ClinicalTrials.gov/show/NCT01480258 Completed MCM Vaccines B.V. 2013-10-09
NCT01466062 Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions https://ClinicalTrials.gov/show/NCT01466062 Completed AbbVie 2012-04-30
NCT01459081 Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China https://ClinicalTrials.gov/show/NCT01459081 Completed Jiangsu Simcere Pharmaceutical Co., Ltd. 2012-12-31
NCT01431898 Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT01431898 Completed Gilead Sciences 2011-12-31
NCT01421121 Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants https://ClinicalTrials.gov/show/NCT01421121 Completed Sinovac Biotech Co., Ltd 2011-09-30
NCT01396512 Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEVâ„¢) Compared to CD.JEVAXâ„¢ in Toddlers https://ClinicalTrials.gov/show/NCT01396512 Completed Sanofi 2013-03-31
NCT01371578 Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT01371578 Completed Gilead Sciences 2013-03-31
NCT01353339 Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study https://ClinicalTrials.gov/show/NCT01353339 Completed Ottawa Hospital Research Institute 2014-04-30
NCT01349543 The Development of a Human Model of Respiratory Syncytial Virus Infection https://ClinicalTrials.gov/show/NCT01349543 Completed Imperial College London 2013-10-31
NCT01347736 Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection https://ClinicalTrials.gov/show/NCT01347736 Completed Mayo Clinic 2012-11-07
NCT01341639 Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) https://ClinicalTrials.gov/show/NCT01341639 Completed MCM Vaccines B.V. 2013-03-13
NCT01340937 A Study of V419 Given Concomitantly With Prevnar 13â„¢ and RotaTeqâ„¢ (V419-006) https://ClinicalTrials.gov/show/NCT01340937 Completed Merck Sharp & Dohme Corp. 2012-12-18
NCT01337167 Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13â„¢ and RotaTeqâ„¢ (V419-005) https://ClinicalTrials.gov/show/NCT01337167 Completed Merck Sharp & Dohme Corp. 2013-05-09
NCT01336010 Treatment of Recently Acquired Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT01336010 Completed Kirby Institute 2015-06-30
NCT04414267 Bacillus Calmette-guérin Vaccination to Prevent COVID-19 https://ClinicalTrials.gov/show/NCT04414267 Recruiting Hellenic Institute for the Study of Sepsis 2021-05-25
NCT04403100 Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: “The Hope Coalition - 1” https://ClinicalTrials.gov/show/NCT04403100 Recruiting Cardresearch 2020-09-03
NCT04398004 Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early https://ClinicalTrials.gov/show/NCT04398004 Recruiting Hellenic Institute for the Study of Sepsis 2022-05-06
NCT04380701 A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults https://ClinicalTrials.gov/show/NCT04380701 Recruiting Biontech SE 2020-08-31
NCT04376034 Convalescent Plasma Collection and Treatment in Pediatrics and Adults https://ClinicalTrials.gov/show/NCT04376034 Recruiting West Virginia University 2021-03-30
NCT04365101 Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19) https://ClinicalTrials.gov/show/NCT04365101 Recruiting Celularity Incorporated 2020-11-30
NCT04363411 Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral Infections https://ClinicalTrials.gov/show/NCT04363411 Completed Hasselt University 2019-10-22
NCT04348864 COVID-19 Antibody Self-testing Using Virtual Point-of-care https://ClinicalTrials.gov/show/NCT04348864 Recruiting Neuroganics LLC 2021-04-30
NCT04333589 Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive https://ClinicalTrials.gov/show/NCT04333589 Recruiting Peking University First Hospital 2020-06-01
NCT04326790 The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention https://ClinicalTrials.gov/show/NCT04326790 Recruiting National and Kapodistrian University of Athens 2020-08-31
NCT04322773 Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure https://ClinicalTrials.gov/show/NCT04322773 Recruiting Frederiksberg University Hospital 2021-06-01
NCT04322396 Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 https://ClinicalTrials.gov/show/NCT04322396 Recruiting Chronic Obstructive Pulmonary Disease Trial Network, Denmark 2020-10-31
NCT04316377 Norwegian Coronavirus Disease 2019 Study https://ClinicalTrials.gov/show/NCT04316377 Active, not recruiting University Hospital, Akershus 2020-05-25
NCT04308317 Tetrandrine Tablets Used in the Treatment of COVID-19 https://ClinicalTrials.gov/show/NCT04308317 Enrolling by invitation Henan Provincial People’s Hospital 2021-03-01
NCT04293042 Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients https://ClinicalTrials.gov/show/NCT04293042 Recruiting Children’s Hospital of Philadelphia 2022-12-30
NCT04288102 Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) https://ClinicalTrials.gov/show/NCT04288102 Active, not recruiting Beijing 302 Hospital 2020-05-12
NCT04258059 Wells and Enteric Disease Transmission Trial (WET - Trial) https://ClinicalTrials.gov/show/NCT04258059 Recruiting Temple University 2021-06-30
NCT04248426 A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection https://ClinicalTrials.gov/show/NCT04248426 Recruiting Antios Therapeutics, Inc 2021-08-31
NCT04244084 Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection https://ClinicalTrials.gov/show/NCT04244084 Completed Materia Medica Holding 2020-04-09
NCT04186000 Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola https://ClinicalTrials.gov/show/NCT04186000 Recruiting Universiteit Antwerpen 2022-07-18
NCT04156217 EBV-TCR-T Cells for EB Virus Infection After HSCT https://ClinicalTrials.gov/show/NCT04156217 Recruiting Hebei Yanda Ludaopei Hospital 2021-11-01
NCT04153279 CMV-TCR-T Cells for CM Virus Infection After HSCT https://ClinicalTrials.gov/show/NCT04153279 Recruiting Hebei Yanda Ludaopei Hospital 2021-10-01
NCT04152486 Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC https://ClinicalTrials.gov/show/NCT04152486 Recruiting London School of Hygiene and Tropical Medicine 2020-11-30
NCT04141930 Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle https://ClinicalTrials.gov/show/NCT04141930 Enrolling by invitation University of Washington 2020-05-01
NCT04141917 Test-and-treat for Influenza in Homeless Shelters https://ClinicalTrials.gov/show/NCT04141917 Recruiting University of Washington 2021-04-30
NCT04139681 Safety and Efficacy of the Sore Throat Lozenges to Treat Acute Sore Throats https://ClinicalTrials.gov/show/NCT04139681 Active, not recruiting Bioforce AG 2019-04-26
NCT04129554 A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection https://ClinicalTrials.gov/show/NCT04129554 Recruiting Janssen Sciences Ireland UC 2022-01-31
NCT04124198 Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT04124198 Recruiting Rigshospitalet, Denmark 2024-01-31
NCT04111367 Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients https://ClinicalTrials.gov/show/NCT04111367 Recruiting Ginkgopharma CO., LTD 2020-04-30
NCT04086472 Phase 2a Respiratory Syncytial Virus (RSV) Human Challenge Study of MK-1654 in Healthy Participants (MK-1654-005) https://ClinicalTrials.gov/show/NCT04086472 Active, not recruiting Merck Sharp & Dohme Corp. 2020-03-22
NCT04081480 Pharmacokinetics of Valacyclovir Oral Solution in Children https://ClinicalTrials.gov/show/NCT04081480 Recruiting Radboud University 2020-09-01
NCT04062669 A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals’ Experimental Rabies Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT04062669 Recruiting GlaxoSmithKline 2020-04-29
NCT04056611 Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV) https://ClinicalTrials.gov/show/NCT04056611 Recruiting Janssen Sciences Ireland UC 2022-08-15
NCT04055454 A Trial to Evaluate the Optimal Dose of MV-LASV https://ClinicalTrials.gov/show/NCT04055454 Recruiting Themis Bioscience GmbH 2020-04-30
NCT04046978 Modelling the Interaction Between Synthetic Model Immunogens and the Induced B and T Cell Repertoires. https://ClinicalTrials.gov/show/NCT04046978 Recruiting Imperial College London 2020-09-30
NCT04042740 Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT04042740 Active, not recruiting AIDS Clinical Trials Group 2023-03-02
NCT04028349 Ebola Vaccine Trial (Ad26.ZEBOV/MVA-BN-Filo) https://ClinicalTrials.gov/show/NCT04028349 Recruiting MRC/UVRI Uganda Research Unit on Aids 2020-07-31
NCT04008004 A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2) https://ClinicalTrials.gov/show/NCT04008004 Active, not recruiting Enanta Pharmaceuticals 2020-12-31
NCT04001608 Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients https://ClinicalTrials.gov/show/NCT04001608 Active, not recruiting Ginkgopharma CO., LTD 2019-07-31
NCT03990766 Smell Changes & Efficacy of Nasal Theophylline https://ClinicalTrials.gov/show/NCT03990766 Recruiting Washington University School of Medicine 2020-06-30
NCT03982186 A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection https://ClinicalTrials.gov/show/NCT03982186 Recruiting Janssen Sciences Ireland UC 2021-03-31
NCT03981822 A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts https://ClinicalTrials.gov/show/NCT03981822 Recruiting Verrica Pharmaceuticals Inc. 2020-08-12
NCT03929757 A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants https://ClinicalTrials.gov/show/NCT03929757 Active, not recruiting Janssen Vaccines & Prevention B.V. 2020-12-22
NCT03916185 Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age https://ClinicalTrials.gov/show/NCT03916185 Recruiting National Institute of Allergy and Infectious Diseases (NIAID) 2020-12-10
NCT03891550 Micro-elimination of Hepatitis C Virus Infection in Uremics https://ClinicalTrials.gov/show/NCT03891550 Recruiting Kaohsiung Medical University Chung-Ho Memorial Hospital 2024-04-15
NCT03830905 Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI https://ClinicalTrials.gov/show/NCT03830905 Recruiting PHARMENTERPRISES LLC 2020-01-31
NCT03818334 Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies https://ClinicalTrials.gov/show/NCT03818334 Recruiting Hospital Israelita Albert Einstein 2021-11-01
NCT03769467 Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) https://ClinicalTrials.gov/show/NCT03769467 Recruiting Atara Biotherapeutics 2023-09-30
NCT03762681 A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection https://ClinicalTrials.gov/show/NCT03762681 Active, not recruiting Hoffmann-La Roche 2021-03-13
NCT03739112 Efficacy of a Plant-derived Quadrivalent VLP Vaccine in the Elderly https://ClinicalTrials.gov/show/NCT03739112 Completed Medicago 2019-05-17
NCT03719586 Investigational Therapeutics for the Treatment of People With Ebola Virus Disease https://ClinicalTrials.gov/show/NCT03719586 Recruiting National Institutes of Health Clinical Center (CC) 2019-09-09
NCT03718130 Combination HTNV and PUUV DNA Vaccine https://ClinicalTrials.gov/show/NCT03718130 Enrolling by invitation U.S. Army Medical Research and Development Command 2020-05-31
NCT03699202 Anti-RSV Study in Chinese Patients (ASCENT) https://ClinicalTrials.gov/show/NCT03699202 Recruiting Ark Biosciences Inc. 2020-01-31
NCT03684668 Psychoeduc Interv. Through Meta-universes on Condom`s Use Self - Efficacy and Sexual Behavior in Students of UAChile https://ClinicalTrials.gov/show/NCT03684668 Recruiting Universidad Autónoma de Chile 2019-12-31
NCT03674125 Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT03674125 Completed GeneOne Life Science, Inc. 2020-04-07
NCT03707912 Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections https://ClinicalTrials.gov/show/NCT03707912 Completed Materia Medica Holding 2019-03-15
NCT03624946 Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG) https://ClinicalTrials.gov/show/NCT03624946 Completed Emergent BioSolutions 2019-03-06
NCT03615183 A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002) https://ClinicalTrials.gov/show/NCT03615183 Completed Merck Sharp & Dohme Corp. 2019-09-26
NCT03598452 High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients https://ClinicalTrials.gov/show/NCT03598452 Completed Aier School of Ophthalmology, Central South University 2018-01-31
NCT03594981 Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis https://ClinicalTrials.gov/show/NCT03594981 Recruiting Children’s National Research Institute 2021-07-31
NCT03584308 Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal https://ClinicalTrials.gov/show/NCT03584308 Completed Catalysis SL 2018-05-15
NCT03487549 Cantharidin and Occlusion in Verruca Epithelium https://ClinicalTrials.gov/show/NCT03487549 Completed Verrica Pharmaceuticals Inc. 2019-05-16
NCT03475056 cAd3-Marburg Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT03475056 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2019-12-19
NCT03473002 A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT03473002 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2019-02-14
NCT03462004 Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein https://ClinicalTrials.gov/show/NCT03462004 Active, not recruiting National Institute of Allergy and Infectious Diseases (NIAID) 2020-10-31
NCT03455491 Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections https://ClinicalTrials.gov/show/NCT03455491 Completed PHARMENTERPRISES LLC 2018-06-28
NCT03441373 XC8 in the Treatment of Patients With Acute Respiratory Viral Infection https://ClinicalTrials.gov/show/NCT03441373 Completed PHARMENTERPRISES LLC 2017-02-09
NCT03425149 Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults https://ClinicalTrials.gov/show/NCT03425149 Completed Valneva Austria GmbH 2018-06-26
NCT01244867 Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine https://ClinicalTrials.gov/show/NCT01244867 Completed Medicago 2011-07-31
NCT01242670 Ross River Virus (RRV) Vaccine Study https://ClinicalTrials.gov/show/NCT01242670 Completed Ology Bioservices 2012-10-31
NCT01241760 VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT01241760 Completed Janssen Infectious Diseases BVBA 2012-08-31
NCT01183611 The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonates https://ClinicalTrials.gov/show/NCT01183611 Completed Jiangsu Province Centers for Disease Control and Prevention 2010-06-30
NCT01136395 Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation https://ClinicalTrials.gov/show/NCT01136395 Completed University of Giessen 2019-06-18
NCT01097395 Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT01097395 Completed University of Colorado, Denver 2015-08-31
NCT01096576 A Study of Balapiravir in Patients With Dengue Virus Infection https://ClinicalTrials.gov/show/NCT01096576 Completed Hoffmann-La Roche 2011-04-30
NCT01090232 Host Responses in Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection https://ClinicalTrials.gov/show/NCT01090232 Completed Assistance Publique Hopitaux De Marseille 2012-02-29
NCT01072695 Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT01072695 Completed Gilead Sciences 2010-10-31
NCT02022163 Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults. https://ClinicalTrials.gov/show/NCT02022163 Completed Medicago 2014-09-30
NCT01032408 Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection https://ClinicalTrials.gov/show/NCT01032408 Completed Chiltern Pesquisa Clinica Ltda 2011-09-30
NCT01021397 Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children https://ClinicalTrials.gov/show/NCT01021397 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2011-12-31
NCT01006629 Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children https://ClinicalTrials.gov/show/NCT01006629 Completed Abbott 2010-04-30
NCT00997607 Evaluating an Ebola and a Marburg Vaccine in Uganda https://ClinicalTrials.gov/show/NCT00997607 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2012-04-30
NCT00984945 Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT00984945 Completed Medicago 2009-12-31
NCT00980447 Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults https://ClinicalTrials.gov/show/NCT00980447 Completed UMN Pharma Inc. 2009-12-31
NCT00975572 Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older https://ClinicalTrials.gov/show/NCT00975572 Completed Jiangsu Province Centers for Disease Control and Prevention 2009-09-30
NCT00973284 Norwalk Vaccine Study https://ClinicalTrials.gov/show/NCT00973284 Completed Takeda 2010-04-07
NCT00949572 Measuring Responses to Sublingual Antigens https://ClinicalTrials.gov/show/NCT00949572 Completed St George’s, University of London 2010-06-30
NCT00948220 Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C https://ClinicalTrials.gov/show/NCT00948220 Completed University of Ulm 2007-01-31
NCT00921726 Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults https://ClinicalTrials.gov/show/NCT00921726 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2009-10-31
NCT00853255 Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults https://ClinicalTrials.gov/show/NCT00853255 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2011-08-31
NCT04369365 A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04369365 Recruiting Medical University of Vienna 2020-08-27
NCT04223037 Purified Inactivated Japanese Encephalitis Vaccine https://ClinicalTrials.gov/show/NCT04223037 Active, not recruiting Chinese Academy of Medical Sciences 2018-03-07
NCT04357366 suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) https://ClinicalTrials.gov/show/NCT04357366 Recruiting Hellenic Institute for the Study of Sepsis 2022-04-15
NCT04339712 Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction https://ClinicalTrials.gov/show/NCT04339712 Recruiting Hellenic Institute for the Study of Sepsis 2022-04-01
NCT03776994 Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine https://ClinicalTrials.gov/show/NCT03776994 Active, not recruiting SRI International 2020-07-31
NCT02755948 A Study of Protective Immunity Against RSV and Influenza in Experimental Human Challenge of Volunteers https://ClinicalTrials.gov/show/NCT02755948 Recruiting Imperial College London 2020-09-30
NCT02094365 A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model https://ClinicalTrials.gov/show/NCT02094365 Completed Alios Biopharma Inc. 2014-06-30
NCT04334265 Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019 https://ClinicalTrials.gov/show/NCT04334265 Recruiting Peking University First Hospital 2020-06-01
NCT03463694 Edinburgh and Lothian Virus Intervention Study in Kids https://ClinicalTrials.gov/show/NCT03463694 Recruiting University of Edinburgh 2020-05-31
NCT03155906 Integrated Treatment of Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT03155906 Active, not recruiting Haukeland University Hospital 2020-05-08
NCT01805752 Optimizing Integrated PMTCT Services in Rural North-Central Nigeria https://ClinicalTrials.gov/show/NCT01805752 Completed Vanderbilt University 2015-12-31
NCT01570283 ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus https://ClinicalTrials.gov/show/NCT01570283 Completed AlloVir 2016-08-31
NCT03883906 Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cell Transplant https://ClinicalTrials.gov/show/NCT03883906 Recruiting Children’s Hospital Medical Center, Cincinnati 2023-03-31
NCT00749580 A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen https://ClinicalTrials.gov/show/NCT00749580 Completed University of South Florida 2011-07-31
NCT00734175 Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine https://ClinicalTrials.gov/show/NCT00734175 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2008-12-31
NCT00722774 Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine https://ClinicalTrials.gov/show/NCT00722774 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2008-09-30
NCT00717834 Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine https://ClinicalTrials.gov/show/NCT00717834 Completed Ology Bioservices 2008-10-31
NCT00711009 Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL) https://ClinicalTrials.gov/show/NCT00711009 Completed Abbott 2009-11-30
NCT00707642 Safety Study of HBV-002 West Nile Vaccine in Healthy Adults https://ClinicalTrials.gov/show/NCT00707642 Completed Hawaii Biotech, Inc. 2009-06-30
NCT00668369 Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation https://ClinicalTrials.gov/show/NCT00668369 Completed Hospital Clinic of Barcelona 2011-09-30
NCT00641017 Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine https://ClinicalTrials.gov/show/NCT00641017 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2012-07-31
NCT00605514 Ebola and Marburg Virus Vaccines https://ClinicalTrials.gov/show/NCT00605514 Completed National Institutes of Health Clinical Center (CC) 2010-06-21
NCT00575185 Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection https://ClinicalTrials.gov/show/NCT00575185 Completed University of Minnesota 2009-07-31
NCT00565539 Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT00565539 Completed ZymoGenetics 2009-10-31
NCT00551915 A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003) https://ClinicalTrials.gov/show/NCT00551915 Completed Merck Sharp & Dohme Corp. 2003-01-31
NCT00551629 A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002) https://ClinicalTrials.gov/show/NCT00551629 Completed Merck Sharp & Dohme Corp. 2003-03-31
NCT00516035 Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults https://ClinicalTrials.gov/show/NCT00516035 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2007-12-31
NCT00502086 Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection. https://ClinicalTrials.gov/show/NCT00502086 Completed Catalysis SL 2009-07-31
NCT00493285 Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age https://ClinicalTrials.gov/show/NCT00493285 Completed MedImmune LLC 2009-11-30
NCT00489931 Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally https://ClinicalTrials.gov/show/NCT00489931 Completed National Institutes of Health Clinical Center (CC) NA
NCT00488046 Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults https://ClinicalTrials.gov/show/NCT00488046 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00444860 ZOSTAVAX(R) Local Registration Trial (V211-019) https://ClinicalTrials.gov/show/NCT00444860 Completed Merck Sharp & Dohme Corp. 2007-05-31
NCT00421304 A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness https://ClinicalTrials.gov/show/NCT00421304 Completed MedImmune LLC 2010-01-31
NCT00408109 Safety Study of Avian Flu Vaccine https://ClinicalTrials.gov/show/NCT00408109 Completed National Institutes of Health Clinical Center (CC) NA
NCT00395018 Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection https://ClinicalTrials.gov/show/NCT00395018 Completed Bristol-Myers Squibb 2011-03-31
NCT00383864 Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation. https://ClinicalTrials.gov/show/NCT00383864 Completed Hospital Clinic of Barcelona NA
NCT00380237 Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B) https://ClinicalTrials.gov/show/NCT00380237 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2007-01-31
NCT00374309 Experimental Vaccine for Prevention of Ebola Virus Infection https://ClinicalTrials.gov/show/NCT00374309 Completed National Institutes of Health Clinical Center (CC) NA
NCT00366782 Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults https://ClinicalTrials.gov/show/NCT00366782 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2011-02-28
NCT00361101 A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus https://ClinicalTrials.gov/show/NCT00361101 Completed Sanofi 2006-08-31
NCT00347672 Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults https://ClinicalTrials.gov/show/NCT00347672 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2007-07-31
NCT00343278 Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets https://ClinicalTrials.gov/show/NCT00343278 Completed GlaxoSmithKline 2005-08-31
NCT00308412 Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants https://ClinicalTrials.gov/show/NCT00308412 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2010-04-30
NCT00294918 An Efficacy and Safety Trial of Serostim® in the Maintenance of the Treatment Effect Obtained During the Study of Serostim® in Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome https://ClinicalTrials.gov/show/NCT00294918 Completed EMD Serono 2003-02-28
NCT00294164 Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS) https://ClinicalTrials.gov/show/NCT00294164 Completed EMD Serono 2002-05-31
NCT00262522 Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects https://ClinicalTrials.gov/show/NCT00262522 Completed Abbott 2008-07-31
NCT00248339 Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT00248339 Completed Virginia Commonwealth University 2005-07-31
NCT00220597 Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse https://ClinicalTrials.gov/show/NCT00220597 Completed Stanford University 2004-12-31
NCT00219453 Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination https://ClinicalTrials.gov/show/NCT00219453 Completed PATH NA
NCT00209352 Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT00209352 Completed Fred Hutchinson Cancer Research Center NA
NCT00194480 Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users https://ClinicalTrials.gov/show/NCT00194480 Completed National Institute on Drug Abuse (NIDA) 2006-12-31
NCT00186927 A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers https://ClinicalTrials.gov/show/NCT00186927 Active, not recruiting St. Jude Children’s Research Hospital 2023-01-31
NCT00180674 Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT00180674 Completed Imperial College London 2006-09-30
NCT00110279 Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A) https://ClinicalTrials.gov/show/NCT00110279 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2005-09-30
NCT00069316 Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease https://ClinicalTrials.gov/show/NCT00069316 Completed National Institutes of Health Clinical Center (CC) 2007-06-27
NCT00047814 Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT00047814 Completed Astellas Pharma Inc NA
NCT00002358 A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV https://ClinicalTrials.gov/show/NCT00002358 Completed Bristol-Myers Squibb NA
NCT00002144 The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment https://ClinicalTrials.gov/show/NCT00002144 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002009 A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia https://ClinicalTrials.gov/show/NCT00002009 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002008 An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia https://ClinicalTrials.gov/show/NCT00002008 Completed NIH AIDS Clinical Trials Information Service NA
NCT00002001 The Antiviral Efficacy of Concurrent Zidovudine and 2’,3’-Dideoxyinosine or 2’,3’-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease https://ClinicalTrials.gov/show/NCT00002001 Completed NIH AIDS Clinical Trials Information Service NA
NCT00000654 The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAU https://ClinicalTrials.gov/show/NCT00000654 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA
NCT00001386 Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection https://ClinicalTrials.gov/show/NCT00001386 Completed National Institutes of Health Clinical Center (CC) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03374566 Immunodeficiency for Severe Epstein-Barr Virus Infection https://ClinicalTrials.gov/show/NCT03374566 Recruiting Children’s Hospital of Fudan University 2022-11-30
NCT03820739 EBOVAC-Salone Extension https://ClinicalTrials.gov/show/NCT03820739 Recruiting London School of Hygiene and Tropical Medicine 2022-09-30
NCT03225794 Simian Foamy Virus Transmission to Humans https://ClinicalTrials.gov/show/NCT03225794 Recruiting Institut Pasteur 2020-10-31
NCT03158818 Chronic Hepatitis B Virus Infection in Zambia https://ClinicalTrials.gov/show/NCT03158818 Recruiting University of Alabama at Birmingham 2021-01-31
NCT03158233 Zika Case Definition and Surveillance Study https://ClinicalTrials.gov/show/NCT03158233 Completed Sanofi 2018-12-19
NCT03149289 Hepatitis C Virus Infection in Patients With Hemoglobinopathies https://ClinicalTrials.gov/show/NCT03149289 Completed Società Italiana Talassemie ed Emoglobinopatie 2016-03-01
NCT03140774 Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines https://ClinicalTrials.gov/show/NCT03140774 Active, not recruiting University of Oxford 2020-07-31
NCT03114267 Involvement of Viral Infections in the Pathogenesis of Chronic Lymphocytic Thyroiditis https://ClinicalTrials.gov/show/NCT03114267 Completed Centre Hospitalier Universitaire, Amiens 2015-01-06
NCT03111745 Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010 https://ClinicalTrials.gov/show/NCT03111745 Completed National Institutes of Health Clinical Center (CC) 2018-12-29
NCT03098862 PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response https://ClinicalTrials.gov/show/NCT03098862 Completed National Institutes of Health Clinical Center (CC) 2019-05-02
NCT03096574 Respiratory Syncytial Virus (RSV) and Vaccination in Pregnancy https://ClinicalTrials.gov/show/NCT03096574 Recruiting University Hospital Southampton NHS Foundation Trust 2019-11-30
NCT03089970 Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients https://ClinicalTrials.gov/show/NCT03089970 Recruiting University of California, Davis 2020-03-31
NCT03075111 Host-based Immunoassay for Differentiating Bacterial From Viral Infections (Post-marketing Study of ImmunoXpertâ„¢) https://ClinicalTrials.gov/show/NCT03075111 Active, not recruiting MeMed Diagnostics Ltd. 2019-02-28
NCT02831699 The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in Mexico https://ClinicalTrials.gov/show/NCT02831699 Completed Mexican Emerging Infectious Diseases Clinical Research Network 2019-01-25
NCT02794181 Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD) https://ClinicalTrials.gov/show/NCT02794181 Completed National Institutes of Health Clinical Center (CC) 2019-03-14
NCT02783976 Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice https://ClinicalTrials.gov/show/NCT02783976 Completed Gilead Sciences 2018-06-20
NCT02758288 BK Virus Post-Kidney Transplant: New Practice Versus Traditional Approach https://ClinicalTrials.gov/show/NCT02758288 Recruiting Loma Linda University 2021-07-31
NCT02658331 Evaluation of the FilmArray BioThreat-E Test https://ClinicalTrials.gov/show/NCT02658331 Completed BioMérieux 2015-07-31
NCT04401436 COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO) https://ClinicalTrials.gov/show/NCT04401436 Recruiting National Institutes of Health Clinical Center (CC) 2022-06-30
NCT02605109 Analysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV) https://ClinicalTrials.gov/show/NCT02605109 Completed Konkuk University Medical Center 2015-11-30
NCT02592057 Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India https://ClinicalTrials.gov/show/NCT02592057 Completed Gilead Sciences 2017-11-30
NCT02856984 Zika in Infants and Pregnancy (ZIP) https://ClinicalTrials.gov/show/NCT02856984 Active, not recruiting RTI International 2020-05-05
NCT01011712 The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise https://ClinicalTrials.gov/show/NCT01011712 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00004850 Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT00004850 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT02562742 Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02562742 Completed Gilead Sciences 2017-06-12
NCT03392207 Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) https://ClinicalTrials.gov/show/NCT03392207 Completed Butantan Institute 2018-07-17
NCT01306084 Viral Infections in Healthy and Immunocompromised Hosts https://ClinicalTrials.gov/show/NCT01306084 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02537379 Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT02537379 Completed Gilead Sciences 2017-06-05
NCT02452229 Review of Human Herpes Viruses in Burns https://ClinicalTrials.gov/show/NCT02452229 Completed The University of Texas Medical Branch, Galveston 2015-05-31
NCT02431923 Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up https://ClinicalTrials.gov/show/NCT02431923 Active, not recruiting National Institutes of Health Clinical Center (CC) 2025-05-31
NCT02335437 Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents https://ClinicalTrials.gov/show/NCT02335437 Completed University Hospital, Akershus 2016-12-31
NCT02273882 An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants https://ClinicalTrials.gov/show/NCT02273882 Completed AstraZeneca 2016-08-19
NCT02260596 Respiratory Viral Infections in Pediatric Transplantation https://ClinicalTrials.gov/show/NCT02260596 Completed Duke University 2015-07-31
NCT02174341 The Pilot Study of Chikungunya Virus Infections in Southern Taiwan https://ClinicalTrials.gov/show/NCT02174341 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2018-07-31
NCT01302418 Collection and Testing of Respiratory Samples https://ClinicalTrials.gov/show/NCT01302418 Completed QIAGEN Gaithersburg, Inc 2011-07-31
NCT01297504 A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America https://ClinicalTrials.gov/show/NCT01297504 Completed AbbVie 2013-08-31
NCT02049918 Residual Sample Collection for Respiratory Viral Panel https://ClinicalTrials.gov/show/NCT02049918 Completed GenMark Diagnostics 2015-11-30
NCT04377724 Spread and Course of COVID-19 Infections https://ClinicalTrials.gov/show/NCT04377724 Active, not recruiting ETH Zurich 2021-06-30
NCT01917461 Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections https://ClinicalTrials.gov/show/NCT01917461 Completed MeMed Diagnostics Ltd. 2013-12-31
NCT01915394 Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial) https://ClinicalTrials.gov/show/NCT01915394 Completed Ankara University 2014-05-31
NCT01754428 Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age https://ClinicalTrials.gov/show/NCT01754428 Completed Gilead Sciences 2013-05-31
NCT01748968 Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence https://ClinicalTrials.gov/show/NCT01748968 Completed VA Eastern Colorado Health Care System 2015-09-30
NCT01732081 “Real-life” Cohort of Patients With Chronic Hepatitis B Virus Infection https://ClinicalTrials.gov/show/NCT01732081 Recruiting University Hospital, Strasbourg, France 2021-01-31
NCT01706302 Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009 https://ClinicalTrials.gov/show/NCT01706302 Completed GlaxoSmithKline 2012-11-30
NCT01662336 Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program https://ClinicalTrials.gov/show/NCT01662336 Completed AbbVie 2016-06-30
NCT01638312 Development of Method of Fructose Identification in Urine to Detect the Viral Infection https://ClinicalTrials.gov/show/NCT01638312 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2013-05-31
NCT01567813 Post-Licensure Study of the Safety of GARDASILâ„¢ in Males (V501-070) https://ClinicalTrials.gov/show/NCT01567813 Completed Merck Sharp & Dohme Corp. 2019-06-01
NCT01545245 Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants https://ClinicalTrials.gov/show/NCT01545245 Completed Tokai University 2014-01-31
NCT01486160 Respiratory Viral Infection in Nursing Home Slovenia https://ClinicalTrials.gov/show/NCT01486160 Completed University Maribor 2012-05-31
NCT04449978 TARGet Kids! COVID-19 Study of Children and Families https://ClinicalTrials.gov/show/NCT04449978 Recruiting The Hospital for Sick Children 2022-06-30
NCT04438629 Evaluation of Immune Response in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04438629 Recruiting Azienda Ospedaliera Universitaria Integrata Verona 2020-06-10
NCT04431050 Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens https://ClinicalTrials.gov/show/NCT04431050 Recruiting Imperial College London 2021-04-30
NCT04423692 Knowledge About Covid-19 Infection https://ClinicalTrials.gov/show/NCT04423692 Recruiting Aljazeera Hospital 2020-06-15
NCT04403061 Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome https://ClinicalTrials.gov/show/NCT04403061 Recruiting Asociacion para el Estudio de las Enfermedades Infecciosas 2020-08-22
NCT04386460 Covid-19 and Prevention of Malnutrition After Confinement by Dentists https://ClinicalTrials.gov/show/NCT04386460 Recruiting Centre Hospitalier Universitaire de Nice 2020-06-05
NCT04374656 Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04374656 Recruiting Johns Hopkins University 2021-05-31
NCT04367740 ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 https://ClinicalTrials.gov/show/NCT04367740 Enrolling by invitation University of North Carolina, Chapel Hill 2021-04-30
NCT04356144 Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections https://ClinicalTrials.gov/show/NCT04356144 Recruiting Medical University of Vienna 2020-10-01
NCT04355481 Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit https://ClinicalTrials.gov/show/NCT04355481 Recruiting Assistance Publique - Hôpitaux de Paris 2020-10-17
NCT04346264 CoVid-19 - Infection and Antibody Formation in the Viennese Population https://ClinicalTrials.gov/show/NCT04346264 Enrolling by invitation Ludwig Boltzmann Institute for Lung Health 2020-06-01
NCT04344327 Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF https://ClinicalTrials.gov/show/NCT04344327 Completed French Cardiology Society 2020-04-21
NCT04332016 COVID-19 Biological Samples Collection https://ClinicalTrials.gov/show/NCT04332016 Recruiting University Hospital, Bordeaux 2023-03-31
NCT04327180 PREdiction of DIagnosed Covid-19 infecTion in IUC Patients https://ClinicalTrials.gov/show/NCT04327180 Recruiting University Hospital, Lille 2021-09-30
NCT04326387 Evaluation of Novel Diagnostic Tests for COVID-19 https://ClinicalTrials.gov/show/NCT04326387 Recruiting Cambridge University Hospitals NHS Foundation Trust 2021-04-07
NCT04290780 COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus https://ClinicalTrials.gov/show/NCT04290780 Recruiting Hospices Civils de Lyon 2020-10-10
NCT04254991 A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-response Based Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Presenting to the ED With Suspicion of Acute Infection https://ClinicalTrials.gov/show/NCT04254991 Active, not recruiting MeMed Diagnostics Ltd. 2018-05-31
NCT04250168 Piloting Clinical Bacteriology in the Ebola Virus Disease Care Response https://ClinicalTrials.gov/show/NCT04250168 Recruiting Institute of Tropical Medicine, Belgium 2020-05-31
NCT04245800 Home Testing of Respiratory Illness https://ClinicalTrials.gov/show/NCT04245800 Active, not recruiting Evidation Health 2020-03-31
NCT04189835 EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients https://ClinicalTrials.gov/show/NCT04189835 Recruiting University of Aarhus 2024-12-03
NCT04182685 Evaluation of Medical Conditions Associated With Zika Virus Infection in Managua, Nicaragua https://ClinicalTrials.gov/show/NCT04182685 Enrolling by invitation RTI International 2020-06-01
NCT04094272 Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT04094272 Completed Kantonsspital Olten 2019-05-01
NCT04026360 Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT04026360 Recruiting University Hospital Inselspital, Berne 2050-08-31
NCT04008823 Study of Influenza Virus Infection in Children Hospitalized in Spain in Two Consecutive Influenza Seasons https://ClinicalTrials.gov/show/NCT04008823 Completed Asociacion Instituto Biodonostia 2017-11-02
NCT03909191 Serum HBV RNA Value on Chronic Hepatitis B Virus Infection Manage https://ClinicalTrials.gov/show/NCT03909191 Active, not recruiting Changhai Hospital 2020-05-01
NCT03865966 Hepatitis B Virus Infection After Liver Transplantation in Children https://ClinicalTrials.gov/show/NCT03865966 Recruiting Children’s Hospital of Chongqing Medical University 2023-12-31
NCT03864263 Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents https://ClinicalTrials.gov/show/NCT03864263 Recruiting Children’s Hospital of Chongqing Medical University 2020-12-31
NCT03846921 Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections https://ClinicalTrials.gov/show/NCT03846921 Recruiting Hillel Yaffe Medical Center 2020-03-31
NCT03816059 Respiratory Virus Infections in Acutely Hospitalized Adult Patients With Pulmonary and Extrapulmonary Complications https://ClinicalTrials.gov/show/NCT03816059 Recruiting The University of Hong Kong 2019-06-30
NCT03813966 Nasal Swab Home Collection Kit (NSHC Kit) Study https://ClinicalTrials.gov/show/NCT03813966 Active, not recruiting University of Wisconsin, Madison 2020-03-04
NCT03757546 Extra-pulmonary Clinical Manifestations of Influenza Virus and Respiratory Syncitial Virus Infections https://ClinicalTrials.gov/show/NCT03757546 Completed Poitiers University Hospital 2019-03-14
NCT03740906 Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting https://ClinicalTrials.gov/show/NCT03740906 Recruiting Kirby Institute 2021-01-31
NCT03736096 Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients https://ClinicalTrials.gov/show/NCT03736096 Recruiting University Hospital, Brest 2019-10-31
NCT03693586 Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis https://ClinicalTrials.gov/show/NCT03693586 Recruiting Hospital General de Mexico 2020-05-01
NCT03684759 Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic Fibrosis https://ClinicalTrials.gov/show/NCT03684759 Completed University Hospital, Brest 2017-02-06
NCT03679728 Sensorimotor Outcomes of Children Exposed to Foetal Zika Virus Infection https://ClinicalTrials.gov/show/NCT03679728 Completed University of Sao Paulo 2016-09-15
NCT03642977 DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant Recipients https://ClinicalTrials.gov/show/NCT03642977 Recruiting University Hospital, Geneva 2020-12-31
NCT03640728 The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure https://ClinicalTrials.gov/show/NCT03640728 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2021-04-30
NCT03557749 Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies https://ClinicalTrials.gov/show/NCT03557749 Recruiting Masonic Cancer Center, University of Minnesota 2030-01-31
NCT03546101 Early Detection of Epstein-Barr Virus Related Disease. https://ClinicalTrials.gov/show/NCT03546101 Active, not recruiting University of Aarhus 2022-03-01
NCT03545919 Clinical Significance of Community-acquired Respiratory Virus Infection and Longitudinal Analysis of the Lung Microbiome in Lung Transplantation https://ClinicalTrials.gov/show/NCT03545919 Recruiting Capital Medical University 2022-06-01
NCT03532971 Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease’s Natural History, Clinical Spectrum, Immunology, and Outcomes https://ClinicalTrials.gov/show/NCT03532971 Recruiting Dana-Farber Cancer Institute 2020-06-30
NCT03529760 Chemotherapy Efficacy and Follow-up Study of Hepatitis B Virus Infection and Reactivation in Children With Leukemia https://ClinicalTrials.gov/show/NCT03529760 Recruiting Children’s Hospital of Chongqing Medical University 2019-07-15
NCT03509701 Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster Virus https://ClinicalTrials.gov/show/NCT03509701 Recruiting Asan Medical Center 2020-04-30
NCT01167361 Epidemiology Of Respiratory Virus Infections In Children https://ClinicalTrials.gov/show/NCT01167361 Completed St. Jude Children’s Research Hospital 2011-10-31
NCT01163240 Epidemiological Study in Children and Adolescents With Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT01163240 Completed Novartis 2011-09-30
NCT01159613 Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection? https://ClinicalTrials.gov/show/NCT01159613 Completed Ziv Hospital 2008-10-31
NCT01112033 Biliverdin Reductase A in Chronic Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT01112033 Completed Charles University, Czech Republic 2013-03-31
NCT01107535 Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection https://ClinicalTrials.gov/show/NCT01107535 Completed Abbott 2011-02-28
NCT01107262 Avian Influenza Studies In Lebanon https://ClinicalTrials.gov/show/NCT01107262 Completed St. Jude Children’s Research Hospital 2010-12-31
NCT01062321 Role of Cytokines in Hepatitis E Virus Infection During Pregnancy https://ClinicalTrials.gov/show/NCT01062321 Completed Maulana Azad Medical College 2012-07-31
NCT01056185 Respiratory Virus Hospitalization Study (FLU 003 Plus) https://ClinicalTrials.gov/show/NCT01056185 Recruiting University of Minnesota 2020-12-31
NCT01030562 Immunogenicity of Off-Schedule Dosing of HPV Vaccine https://ClinicalTrials.gov/show/NCT01030562 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2014-03-05
NCT00921934 Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles https://ClinicalTrials.gov/show/NCT00921934 Completed Pascoe Pharmazeutische Praeparate GmbH 2010-12-31
NCT04323787 Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry https://ClinicalTrials.gov/show/NCT04323787 Recruiting Mayo Clinic 2021-04-30
NCT02715752 A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin https://ClinicalTrials.gov/show/NCT02715752 Completed The Center for the Biology of Chronic Disease 2016-03-31
NCT00807378 Rijavithi Viral and Mycobacterium PCR Arrays in CNS Infection Study https://ClinicalTrials.gov/show/NCT00807378 Completed Rajavithi Hospital 2009-12-31
NCT00533182 Influenza in People With Normal and Weakened Immune Systems https://ClinicalTrials.gov/show/NCT00533182 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT04038372 Hepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive Individuals https://ClinicalTrials.gov/show/NCT04038372 Completed Assiut University 2017-10-31
NCT03192072 A Rapid Test for Acute Respiratory Illness https://ClinicalTrials.gov/show/NCT03192072 Completed Duke University 2019-09-06
NCT04336761 Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France https://ClinicalTrials.gov/show/NCT04336761 Recruiting University Hospital, Lille 2020-12-31
NCT00701922 Surveillance Study of Viral Infections Following Lung Transplantation https://ClinicalTrials.gov/show/NCT00701922 Completed Hannover Medical School 2007-12-31
NCT00667303 Prospective Surveillance For Respiratory Virus Infections In Children Undergoing Hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00667303 Completed St. Jude Children’s Research Hospital 2011-08-31
NCT00606528 FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy https://ClinicalTrials.gov/show/NCT00606528 Completed University Health Network, Toronto 2013-07-31
NCT00585481 Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian Children https://ClinicalTrials.gov/show/NCT00585481 Completed Abbott 2010-12-31
NCT00577525 Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic Syndrome https://ClinicalTrials.gov/show/NCT00577525 Completed Assistance Publique - Hôpitaux de Paris 2010-07-31
NCT00448604 Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations https://ClinicalTrials.gov/show/NCT00448604 Completed University Hospital, Geneva 2009-09-30
NCT00420966 Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy https://ClinicalTrials.gov/show/NCT00420966 Completed Sunnybrook Health Sciences Centre 2017-06-26
NCT00341211 Specimens From Normal Controls https://ClinicalTrials.gov/show/NCT00341211 Completed National Institutes of Health Clinical Center (CC) NA
NCT00341081 Validation of Self-Reported Needle Sharing Among Injection Drug Users https://ClinicalTrials.gov/show/NCT00341081 Completed National Institutes of Health Clinical Center (CC) NA
NCT00247884 Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCV https://ClinicalTrials.gov/show/NCT00247884 Completed University of British Columbia NA
NCT00192686 Cultures a.m.Kamme-Lindbergh in Suspicion of Infected TKA https://ClinicalTrials.gov/show/NCT00192686 Completed Northern Orthopaedic Division, Denmark 2006-11-30
NCT00138463 West Nile Virus Natural History https://ClinicalTrials.gov/show/NCT00138463 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2008-12-31
NCT00069303 Natural History of West Nile Virus Infection https://ClinicalTrials.gov/show/NCT00069303 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001164 Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers https://ClinicalTrials.gov/show/NCT00001164 Completed National Institutes of Health Clinical Center (CC) NA
NCT00023023 Study of Transfusion-Transmitted Infections https://ClinicalTrials.gov/show/NCT00023023 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00006518 Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer https://ClinicalTrials.gov/show/NCT00006518 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00005936 Collection of Liver Tissue for Virologic Studies https://ClinicalTrials.gov/show/NCT00005936 Completed National Institutes of Health Clinical Center (CC) NA
NCT00005657 Genetics of Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT00005657 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04319016 Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy https://ClinicalTrials.gov/show/NCT04319016 Recruiting Federico II University 2020-04-30
NCT02969668 Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients https://ClinicalTrials.gov/show/NCT02969668 Active, not recruiting Universitätsklinikum Hamburg-Eppendorf 2018-10-31
NCT04412551 Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19 https://ClinicalTrials.gov/show/NCT04412551 Recruiting Dalarna County Council, Sweden 2020-12-31
NCT04315870 Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy. https://ClinicalTrials.gov/show/NCT04315870 Recruiting Federico II University 2020-04-20
NCT04088916 Proviral DNA as a Target for HIV-1 Resistance Analysis https://ClinicalTrials.gov/show/NCT04088916 Recruiting University of Chile 2019-09-08
NCT03631719 Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia https://ClinicalTrials.gov/show/NCT03631719 Recruiting Universidad de Antioquia 2019-12-31
NCT03587714 Prevalence of Hepatitis c Virus Infection Among Rheumatological Patients https://ClinicalTrials.gov/show/NCT03587714 Completed Assiut University 2017-12-01